Innate Pharma
IPHA
#8501
Rank
C$0.18 B
Marketcap
$2.27
Share price
3.82%
Change (1 day)
-31.20%
Change (1 year)

Innate Pharma (IPHA) - Total debt

Total debt on the balance sheet as of December 2023 : C$61.46 Million

According to Innate Pharma 's latest financial reports the company's total debt is C$61.46 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Innate Pharma - Total debt on balance sheet (from 2009 to 2023)

Total debt by year

Year Total debt Change
2022-12-31C$61.49 M-3.71%
2021-12-31C$63.86 M113.36%
2020-12-31C$29.93 M9.28%
2019-12-31C$27.39 M288.73%
2018-12-31C$7.04 M-20.34%
2017-12-31C$8.84 M17.48%
2016-12-31C$7.52 M32.24%
2015-12-31C$5.69 M-4.08%
2014-12-31C$5.93 M-16.21%
2013-12-31C$7.08 M19.55%
2012-12-31C$5.92 M-33.74%
2011-12-31C$8.94 M0.99%
2010-12-31C$8.85 M-22.24%
2009-12-31C$11.38 M5.19%
2008-12-31C$10.82 M
2006-12-31C$5.08 M535.32%
2005-12-31C$0.79 M